Evidence map›Paper›PMID 20923200›Full record

ArticleACS chemical biology2010

A biosynthetic strategy for re-engineering the Staphylococcus aureus cell wall with non-native small molecules.

James W Nelson, Alexander G Chamessian, Patrick J McEnaney, Ryan P Murelli, Barbara I Kazmierczak, Barbara I Kazmiercak, David A Spiegel

Erratum issuedAbstract read
In one paragraph

Article in ACS chemical biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. A How-To Guide for Mode of Action Analysis of Antimicrobial Peptides.Frontiers in cellular and infection microbiology · 2020
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Immuno-targeting ofChemical science · 2017
    Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Kazmiercak, Barbara I [corrected to Kazmierczak, Barbara I]
5 · Who and what money

Authors and funding

7 authors.

James W NelsonDepartment of Chemistry, Yale University, New Haven, Connecticut 06520, USA.
Alexander G Chamessian
Patrick J McEnaney
Ryan P Murelli
Barbara I Kazmierczak
Barbara I Kazmiercak
David A Spiegel

Funding

Small-Molecule Antibody Recruiting Therapeutics for Treating Human DiseaseDP2OD002913 · OD · YALE UNIVERSITY · PI SPIEGEL, DAVID A · 2007 to 2009
$2.6M
NIH HHS DP22OD002913NIH HHS DP2 OD002913
6 · The paper itself

Abstract

Staphylococcus aureus (S. aureus) is a Gram-positive bacterial pathogen that has emerged as a major public health threat. Here we report that the cell wall of S. aureus can be covalently re-engineered to contain non-native small molecules. This process makes use of endogenous levels of the bacterial enzyme sortase A (SrtA), which ordinarily functions to incorporate proteins into the bacterial cell wall. Thus, incubation of wild-type bacteria with rationally designed SrtA substrates results in covalent incorporation of functional molecular handles (fluorescein, biotin, and azide) into cell wall peptidoglycan. These conclusions are supported by data obtained through a variety of experimental techniques (epifluorescence and electron microscopy, biochemical extraction, and mass spectrometry), and cell-wall-incorporated azide was exploited as a chemical handle to perform an azide-alkyne cycloaddition reaction on the bacterial cell surface. This report represents the first example of cell wall engineering of S. aureus or any other pathogenic Gram-positive bacteria and has the potential for widespread utility.

Indexed as

AminoacyltransferasesBacterial ProteinsCell WallCyclizationCysteine EndopeptidasesStaphylococcus aureusSubstrate SpecificityAminoacyltransferasesBacterial ProteinsCysteine Endopeptidasessortase A

Identifiers

PMID20923200
PMCPMC3003768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.